Aviva launches service for genome-wide detection
launched by Aviva Systems Biology which make available a method for
genome-wide detection of promoters and enhancers that interact with
proteins or carry modifications.
The technology is a leap forward in accelerating new scientific discoveries by allowing researchers to send in their cell/tissue samples or chromatin immunoprecipitated (ChIP) DNA samples, and in return, receive a list of potentially enriched genes.
The ChIP-GLAS system. ChIP-GLAS (Chromatin Immunoprecipitation-Guided Ligation And Selection) is a very sensitive method for genome-wide detection of promoters and enhancers that interact with proteins or carry modifications, such as methylation, that affect gene expression.
"We are pleased to offer this valuable service to our customers offering over 1000 new antibodies for human and mouse transcription factors in 2006," said Julian Yuan, CEO of Aviva Systems Biology.
"We are excited to help accelerate new scientific discoveries," he added.
ChIP-GLAS technology has many important applications that are useful for the understanding of transcription factor/DNA interactions: transcriptional regulation, DNA methylation, mRNA splicing, DNA damage repair, DNA replication, gene deletion and duplication, and many others.
In the ChIP-GLAS procedure, DNA that is bound to transcription factors or hypermethylated is captured, either by a protein-specific antibody or a DNA modification-specific antibody.
The captured DNA is then copied, amplified, and finally hybridised to a promoter microarray to reveal the identity of the genes of interest.
A unique feature of the ChIP-GLAS system is the GLAS (Guided Ligation And Selection) step.
In this step the DNA of interest is specifically selected by annealing to oligonucleotides corresponding to promoters on the microarray.
This step decreases the sample complexity, thereby increasing both the sensitivity and the specificity of ChIP-GLAS compared to similar techniques.
The annealing step is followed by PCR amplification, labelling, and hybridisation to a promoter microarray.
Aviva Systems Biology has further developed this technology using its core bioinformatics capabilities to identify and select the basic promoter regions for the microarray oligo designs.
20,000 human and 8000 mouse promoters have been incorporated into the DNA microarrays as the H20K and M8K chips, respectively.
